Experiment: 29SB

Solution structure of inhibitor (6-NBT)-bound de novo designed Kemp eliminase KABLE2.5.

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N HSQC	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
2	2D 1H-13C HSQC aliphatic	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
3	3D HNCACB	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
4	3D HN(COCA)CB	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
5	3D HNCO	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
6	3D HN(CA)CO	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
7	3D HBHA(CO)NH	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
8	3D HCCH-TOCSY	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
9	2D 1H-13C HSQC aromatic	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
10	3D 1H-15N NOESY	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
11	3D 1H-13C NOESY aliphatic	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
12	2D (HB)CB(CGCD)HD	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
13	2D (HB)CB(CGCDCE)HE	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
14	2D CB-CG	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800
15	3D 1H-13C NOESY aromatic	2 mM [U-100% 13C; U-100% 15N] KABLE2.5, 100 mM sodium chloride, 20 mM HEPES, 10 % [U-2H] D2O, 90 % H2O, 8 mM 6-NBT, 7.4 % v/v [U-2H] CD3CN	90% H2O/10% D2O	118 mM	6.9	1 atm	298	Bruker AVANCE III 800

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE III	800

NMR Refinement
Method	Details	Software
simulated annealing		CNS
torsion angle dynamics		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	100
Conformers Submitted Total Number	10
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	collection	TopSpin	3.7	Bruker Biospin
2	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
3	chemical shift assignment	CcpNmr Analysis		CCPN
4	peak picking	CcpNmr Analysis		CCPN
5	data analysis	CcpNmr Analysis		CCPN
6	processing	TopSpin		Bruker Biospin
7	structure calculation	CYANA		Guntert, Mumenthaler and Wuthrich
8	refinement	CNS		Brunger, Adams, Clore, Gros, Nilges and Read
9	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB is hosted by

RCSB PDB is a member of

RCSB Partners
Nucleic Acid Knowledgebase

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729. RCSB PDB uses resources of the National Energy Research Scientific Computing Center (NERSC), a Department of Energy User Facility.

29SB | pdb_000029sb

Solution structure of inhibitor (6-NBT)-bound de novo designed Kemp eliminase KABLE2.5.